Company Data
Clene Inc.
Ticker
CLNN
Current Price
$8.25 -4.01%
Market Cap
$82.4M
Price Target
Refer to Report
Volume
174.2K
52wk Range
$2.2801 - $11.064
Overview
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).